GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,000 | -3.6% | 46,340 | +9.4% | 0.00% | – |
| Q2 2023 | $83,000 | +9.2% | 42,340 | +54.9% | 0.00% | – |
| Q1 2023 | $76,000 | -22.4% | 27,340 | -3.5% | 0.00% | – |
| Q4 2022 | $98,000 | +46.3% | 28,340 | +7.6% | 0.00% | – |
| Q3 2022 | $67,000 | +11.7% | 26,340 | +6.0% | 0.00% | – |
| Q2 2022 | $60,000 | -41.2% | 24,840 | 0.0% | 0.00% | – |
| Q1 2022 | $102,000 | -61.5% | 24,840 | +22.1% | 0.00% | -100.0% |
| Q4 2021 | $265,000 | -24.7% | 20,351 | -37.7% | 0.00% | 0.0% |
| Q3 2021 | $352,000 | +8.3% | 32,690 | -8.3% | 0.00% | 0.0% |
| Q2 2021 | $325,000 | +3.2% | 35,640 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $315,000 | +238.7% | 33,400 | +42.1% | 0.00% | – |
| Q4 2020 | $93,000 | +86.0% | 23,500 | +23.7% | 0.00% | – |
| Q3 2020 | $50,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |